Benzimidazolone derivatives

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Parasitic organism or component thereof or substance...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

548305, C07D23526, A61K 31415

Patent

active

042095271

ABSTRACT:
A series of novel 3-(substituted methyl)-2-oxo-1-benzimidazolinalkanoic acid compounds has been prepared, including their lower alkyl esters and unsubstituted amide derivatives, as well as the base salts of said acids with pharmacologically acceptable cations. These particular compounds are useful in therapy as aldose reductase inhibitors for the control of certain chronic diabetic complications. Typical members include those compounds derived from 2-oxo-1-benzimidazoline-acetic acid wherein a benzyl moiety is substituted at the 3-position of the molecule. Methods for preparing these compounds from known starting materials are provided.

REFERENCES:
patent: 3661921 (1972-05-01), Umio
patent: 3821383 (1974-06-01), Sestanj et al.
patent: 4161603 (1979-07-01), Habermeier
Davoll et al., J. Chem. Soc. (London) C, 1960, pp. 314-318.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Benzimidazolone derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Benzimidazolone derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzimidazolone derivatives will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1480774

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.